3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
11
Carcinoma, Ovarian Epithelial
2
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Lethal Congenital Contracture Syndrome 2
1
Hodgkin Disease
1
Graft vs Host Disease
1
Esophageal Squamous Cell Carcinoma
1
Interventions
pembrolizumab
6
Drug Therapy
3
Cyclophosphamide
3
spartalizumab
2
fludarabine
2
Sirolimus
2
Riluzole
2
Oncolytic Virotherapy
2
Ipilimumab
2
Blood Specimen Collection
2
vofatamab
1
tocilizumab
1
saracatinib
1
poly ICLC
1
pertuzumab
1
pazopanib
1
liposomal doxorubicin
1
ixabepilone
1
fludarabine phosphate
1
enzalutamide
1
durvalumab
1
cediranib
1
brodalumab
1
atezolizumab
1
aldesleukin
1
advexin
1
Ultrasonography
1
Tissue Banks
1
TKM-080301
1
Ritonavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
In Situ Hybridization, Fluorescence
×
Breast
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled